The CT Swirl Sign Is Associated with Hematoma Expansion in Intracerebral Hemorrhage

References

1. 1.↵
   2. Meretoja A,
   3. Churilov L,
   4. Campbell BC, et al

   . The spot sign and tranexamic acid on preventing ICH growth: AUStralasia Trial (STOP-AUST)—protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial. Int J Stroke 2014;9:519–24 doi:10.1111/ijs.12132 pmid:23981692

   CrossRefPubMed
2. 2.↵
   2. Flaherty ML,
   3. Haverbusch M,
   4. Sekar P, et al

   . Long-term mortality after intracerebral hemorrhage. Neurology 2006;66:1182–86 doi:10.1212/01.wnl.0000208400.08722.7c pmid:16636234

   CrossRefPubMed
3. 3.↵
   2. Hemphill JC 3rd.,
   3. Bonovich DC,
   4. Besmertis L, et al

   . The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001;32:891–97 doi:10.1161/01.STR.32.4.891 pmid:11283388

   Abstract/FREE Full Text
4. 4.↵
   2. Curtze S,
   3. Strbian D,
   4. Meretoja A, et al

   . Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use. Eur J Neurol 2014;21:616–22 doi:10.1111/ene.12352 pmid:24447727

   CrossRefPubMed
5. 5.↵
   2. Davis SM,
   3. Broderick J,
   4. Hennerici M, et al

   ; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006;66:1175–81 pmid:16636233

   Abstract/FREE Full Text
6. 6.↵
   2. Brott T,
   3. Broderick J,
   4. Kothari R, et al

   . Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28:1–5 doi:10.1161/01.STR.28.1.1 pmid:8996478

   Abstract/FREE Full Text
7. 7.↵
   2. Edavettal M,
   3. Rogers A,
   4. Rogers F, et al

   . Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients. Am Surg 2014;80:372–76 pmid:24887668

   PubMed
8. 8.↵
   2. Romero JM,
   3. Heit JJ,
   4. Delgado Almandoz JE, et al

   . Spot sign score predicts rapid bleeding in spontaneous intracerebral hemorrhage. Emerg Radiol 2012;19:195–202 doi:10.1007/s10140-012-1020-9 pmid:22271362

   CrossRefPubMed
9. 9.↵
   2. Hill MD,
   3. Muir KW

   . INTERACT-2: should blood pressure be aggressively lowered acutely after intracerebral hemorrhage? Stroke 2013;44:2951–52 doi:10.1161/STROKEAHA.113.002790 pmid:23988644

   FREE Full Text
10. 10.↵
    2. Gladstone D

    . “Spot Sign” Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy (SPOTLIGHT). 2011. https://clinicaltrials.gov/ct2/show/NCT01359202. Accessed May 1, 2017.
11. 11.↵
    2. Qureshi AI,
    3. Palesch YY

    . Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care 2011;15:559–76 doi:10.1007/s12028-011-9538-3 pmid:21626077

    CrossRefPubMed
12. 12.↵
    2. Huynh TJ,
    3. Demchuk AM,
    4. Dowlatshahi D, et al

    ; PREDICT/Sunnybrook ICH CTA Study Group. Spot sign number is the most important spot sign characteristic for predicting hematoma expansion using first-pass computed tomography angiography: analysis from the PREDICT study. Stroke 2013;44:972–77 doi:10.1161/STROKEAHA.111.000410 pmid:23444309

    Abstract/FREE Full Text
13. 13.↵
    2. Demchuk AM,
    3. Dowlatshahi D,
    4. Rodriguez-Luna D, et al

    ; PREDICT/Sunnybrook ICH CTA study group. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol 2012;11:307–14 doi:10.1016/S1474-4422(12)70038-8 pmid:22405630

    CrossRefPubMed
14. 14.↵
    2. Delgado Almandoz JE,
    3. Yoo AJ,
    4. Stone MJ, et al

    . Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score. Stroke 2009;40:2994–3000 doi:10.1161/STROKEAHA.109.554667 pmid:19574553

    Abstract/FREE Full Text
15. 15.↵
    2. Rost NS,
    3. Smith EE,
    4. Chang Y, et al

    . Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke 2008;39:2304–09 doi:10.1161/STROKEAHA.107.512202 pmid:18556582

    Abstract/FREE Full Text
16. 16.↵
    2. Broderick JP,
    3. Diringer MN,
    4. Hill MD, et al

    ; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke 2007;38:1072–75 doi:10.1161/01.STR.0000258078.35316.30 pmid:17290026

    Abstract/FREE Full Text
17. 17.↵
    2. Godoy DA,
    3. Piñero G,
    4. Di Napoli M

    . Predicting mortality in spontaneous intracerebral hemorrhage: can modification to original score improve the prediction? Stroke 2006;37:1038–44 doi:10.1161/01.STR.0000206441.79646.49 pmid:16514104

    Abstract/FREE Full Text
18. 18.↵
    2. Leys D,
    3. Cordonnier C,
    4. Debette S, et al

    ; Executive committee of the European Stroke Initiative (EUSI). Facilities available in French hospitals treating acute stroke patients: comparison with 24 other European countries. J Neurology 2009;256:867–73 doi:10.1007/s00415-009-5029-2 pmid:19252801

    CrossRefPubMed
19. 19.↵
    2. Goldstein LB

    . Statewide hospital-based stroke services in North Carolina: changes over 10 years. Stroke 2010;41:778–83 doi:10.1161/STROKEAHA.109.572750 pmid:20167914

    Abstract/FREE Full Text
20. 20.↵
    2. Al-Nakshabandi NA

    . The swirl sign. Radiology 2001;218:433 doi:10.1148/radiology.218.2.r01fe09433 pmid:11161158

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Selariu E,
    3. Zia E,
    4. Brizzi M, et al

    . Swirl sign in intracerebral haemorrhage: definition, prevalence, reliability and prognostic value. BMC Neurol 2012;12:109 doi:10.1186/1471-2377-12-109 pmid:23013418

    CrossRefPubMed
22. 22.↵
    2. Gökçe E,
    3. Beyhan M,
    4. Acu B

    . Evaluation of oral anticoagulant-associated intracranial parenchymal hematomas using CT findings. Clin Neuroradiol 2015;25:151–59 doi:10.1007/s00062-014-0292-8 pmid:24474263

    CrossRefPubMed
23. 23.↵
    2. Ma M,
    3. Meretoja A,
    4. Churilov L, et al

    . Warfarin-associated intracerebral hemorrhage: volume, anticoagulation intensity and location. J Neurol Sci 2013;332:75–79 doi:10.1016/j.jns.2013.06.020 pmid:23911098

    CrossRefPubMed
24. 24.↵
    2. Landis JR,
    3. Koch GG

    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74 doi:10.2307/2529310 pmid:843571

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Zimmerman RA,
    3. Bilaniuk LT

    . Computed tomographic staging of traumatic epidural bleeding. Radiology 1982;144:809–12 doi:10.1148/radiology.144.4.7111729 pmid:7111729

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Greenberg J,
    3. Cohen WA,
    4. Cooper PR

    . The “hyperacute” extra-axial intracranial hematoma: computed tomographic findings and clinical significance. Neurosurgery 1985;17:48–56 doi:10.1227/00006123-198507000-00008 pmid:4022287

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Kim J,
    3. Smith A,
    4. Hemphill JC 3rd., et al

    . Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol 2008;29:520–25 doi:10.3174/ajnr.A0859 pmid:18065505

    Abstract/FREE Full Text
28. 28.↵
    2. Hallevi H,
    3. Abraham AT,
    4. Barreto AD, et al

    . The spot sign in intracerebral hemorrhage: the importance of looking for contrast extravasation. Cerebrovasc Dis 2010;29:217–20 doi:10.1159/000267842 pmid:20029193

    CrossRefPubMed